Nucleic Acid Extraction Kits
  • Home
  • Next Generation Sequencing (NGS) Clinical Panels

Next Generation Sequencing (NGS) Clinical Panels

Genes2Me NGS based Clinical Panels cover wide range of genetic mutations and offer innovative, robust, and rapid diagnostic technology bringing the right solution to customers.


  • Exceptional panel performance achieved by hybridization-based target capture method
  • Reduced NGS costs by Pre-capture pooling with no compromise on quality
  • Compatible with all NGS Instruments from Illumina, Thermo Fisher Scientific, Pacific Bioscience, MGI, and Oxford Nanopore
  • User-friendly Bioinformatics Software

Specialized NGS Clinical Panels for Following Disorders

  • Genes2Me NGS Clinical Panels capture ‘Hard to Capture’ regions while analyzing multiple genes associated with a particular disorder or group of disorders. We provide high quality sequencing and are capable of specifically isolating the genomic loci of interest out of whole genome and enhanced sensitivity of detecting genetic mutations by producing higher coverage and in depth sequencing data.
Pan Cancer Panel - NGS
Pan Cancer Panel
Genes2Me Pan Cancer Panel detects all variant types and immuno-oncology markers (MSI and TMB), that are crucial biomarkers for cancer immunotherapy.

LEARN MORE

Barr virus (EBV) and Human Papillomaviruses (HPV), allowing for the comprehensive analysis of cancer-associated genes.
Oncology Panels - NGS
Oncology Panels
The Oncology Panels include various NGS assays designed to detect different types of variants in genes associated with different cancer types.

LEARN MORE

• BRCA1/2 Panel (Somatic/ Germline): Genes2Me BRCA1/2 Panel is designed to target whole exon regions of BRCA1, 2 genes which are associated with increased risk of developing cancer, especially in women.
• Common Hereditary Cancer NGS Panel: Genes2Me Common Hereditary Cancer NGS Panel is an NGS assay designed to detect all types of variants in 61 genes associated with Common Hereditary Cancers.
• Lymphoid Leukemia NGS Panel: Genes2Me Lymphoid Leukemia NGS Panel is an NGS assay designed to detect all types of variants in 75 genes associated with Lymphoid Leukemia.
• Lymphoma NGS Panel: Genes2Me Lymphoma NGS Panel is an NGS assay designed to detect all types of variants in 75 genes associated with Lymphoma.
• Myeloid Leukemia NGS Panel: Genes2Me Myeloid Leukemia NGS Panel is an NGS assay designed to detect all types of variants in over 49 genes associated with Myeloid Leukemia.
Liquid Biopsy Panels - NGS
Liquid Biopsy Panels
Genes2Me Liquid Biopsy Panel is highly optimized clinical panel with exceptional accuracy that detects ctDNA associated with colorectal cancer, breast cancer, and lung cancer.

LEARN MORE

• ctDNA Colorectal Panel: Genes2Me ctDNA Colorectal Panel detects all types of variants in over 16 genes associated with colorectal cancer
• ctDNA Breast Panel: Genes2Me ctDNA Breast Panel detects all types of variants in over 27 genes associated with breast cancer
• ctDNA Lung Panel: Genes2Me ctDNA Lung Panel detects all types of variants in over 28 genes associated with lung cancer
Cancer Check Panel - NGS
Cancer Check Panel
Cancer Check Panels are NGS assays designed to detect all types of variants associated with somatic cancer. Targeting the selected genes with high sensitivity and specificity enables saving cost and effort. The report consists of the primary, secondary, and tertiary results for the In-depth understanding and interpretation of sequencing data.

LEARN MORE

• CancerCheck 50 Panel: Genes2Me ctDNA Colorectal Panel detects all types of variants in over 16 genes associated with colorectal cancer
• CancerCheck 100 Panel: Genes2Me ctDNA Breast Panel detects all types of variants in over 27 genes associated with breast cancer
Oncocheck Panel - NGS
OncoCheck Panel - Hereditary Cancer (Germline Cancer Panel)
Genes2Me OncoCheck panel analyzes 31 oncogenes associated with inherited cancer and precisely provides information for

LEARN MORE

HDR grade computation to aid precision medicine for tumor treatment.
Med4Me Precision Medicine Panel - NGS
Med4Me Precision Medicine Panel
Genes2Me Med4Me Panels target the genes associated with prescribed drugs of the corresponding diseases. The assay allows for precise selection and dosage of prescribed drugs, and detection of genetic variants associated with drug metabolism, epilepsy and anti-tuberculosis.

LEARN MORE

• Med4Me Standard Panel: Genes2Me Med4Me Standard Panel is a NGS assay, designed to assess 122 genes associated with pharmacogenomics.
• Med4Me Epilepsy Panel: Genes2Me Med4Me Epilepsy Panel assesses 91 genes associated with anti-epileptic drugs
• Med4Me Anti-tuberculosis Panel: Genes2Me Med4Me Anti-tuberculosis Panel assesses 132 genes associated with liver injury including Drug-induced liver injury (DILI), which is an important cause of acute liver failure.
Comprehensive Respiratory Virus Panel - CRVP
Comprehensive Respiratory Virus Panel (CRVP)
Genes2Me Comprehensive Respiratory Virus Panel (CRVP) detects and sequence respiratory disease-causing viruses in humans using the NCBI RefSeq database as its foundation.

LEARN MORE

It enables simultaneous testing of 9 different virus types and its 39 strains of clinically significant and prevalent respiratory viruses, including Coronavirus and Influenza.
Clinical Exome Sequencing Panel
Clinical Exome Sequencing (CES) Expanded Panel
The Clinical Exome Sequencing (CES) Expanded Panel analyzes clinical diseases with Whole Exome Sequencing and by selectively

LEARN MORE

targeting the clinically significant genes, this panel enables comprehensive analysis with the most effective sequencing throughput.
HLA Typing NGS Panel
HLA Typing NGS Panel for Donor Selection
HLA Typing NGS Panel is specific to figure out safe donors of organ, bone marrow, stem cell or tissue transplant to the desired recipient.

LEARN MORE

This test features amplification of six specific Human Leukocyte Antigen (HLA) genes present in Major Histocompatibility Complex (MHC) region with deep coverage (≥1000x) and ultra high-allelic resolution.
Neurological Disorders - NGS Clinical Panel
Neurological Disorders
Many neurological conditions are caused by immensely heterogeneous gene mutations. NGS has shortened the ‘Diagnostic Odyssey’ for many of these patients.

LEARN MORE

• Neuromuscular NGS Panel: Genes2Me Neuromuscular NGS Panel assesses 293 genes associated with Movement disorders, Neuromuscular disorders, Charcot-Marie-Tooth Disease and Muscular Dystrophy
• Epilepsy NGS Panel: Genes2Me Epilepsy NGS Panel assesses 142 genes associated with epilepsy disorder
• Alzheimer-Dementia NGS Panel: Genes2Me Alzheimer-Dementia NGS Panel assesses 101 genes associated with Alzheimer-Dementia disorder
Cardiovascular NGS Panel
Cardiovascular Disorders
Cardiovascular NGS Panel: Genes2Me Cardiovascular NGS Panel assesses 174 genes associated with Aortopathy and connective tissue disorders, Arrhythmia,

LEARN MORE

Cardiomyopathy, Congenital heart defect, Dyslipidemia, Pulmonary hypertension and other cardiovascular diseases.
Metabolic Disorders NFS Panel
Other Panels
Metabolic Disorders NGS Panel: Genes2Me Metabolic Disorders NGS Panel includes Coverage of 71 genes with Whole CDS and hotspots as Target Regions/h6>

LEARN MORE

Bleeding Disorder/ Coagulopathy NGS Panel: Genes2Me Bleeding Disorder/ Coagulopathy NGS Panel includes Coverage of 139 genes with Whole CDS and hotspots as Target Regions
Skin Disorders NGS Panel: Genes2Me includes Coverage of 152 genes with Whole CDS and hotspots as Target Regions

Disclaimer: All products listed above are the products of Genes2Me Private Limited. Apart from that, all other product names, trademarks and logos wherever used are the

property of their respective owners.


For More Information Download Brochure
ibrandox